Indegene Ltd's Q4FY25 Quarterly Results

Result Summary

• Indegene Ltd reported a 8.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
• Its expenses for the quarter were down by 7.6% QoQ and - - YoY.
• The net profit decreased 13.6% QoQ and - - YoY.
• The earnings per share (EPS) of Indegene Ltd stood at 4.2 during Q4FY25.

Financial Statments for Q4FY25

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Indegene Ltd is a company that operates within the healthcare solutions industry. It specializes in providing integrated services that enable healthcare organizations to enhance their clinical, medical, and commercial outcomes. The company is known for its innovative solutions that leverage deep industry expertise and advanced analytics to address complex business challenges faced by pharmaceutical companies, healthcare providers, and payers. While recent major developments in the company are not specified, Indegene continues to focus on leveraging technology and domain knowledge to drive growth and efficiency for its clients.

Revenue

In the fourth quarter of the fiscal year 2025 (Q4FY25), Indegene Ltd reported a total income of ₹696.20 crores. This figure represents a decrease of 8.2% when compared to the previous quarter (Q3FY25), where the company recorded a total income of ₹758.10 crores. Unfortunately, year-over-year comparisons cannot be made due to the absence of data from Q4FY24. The decline in revenue on a quarter-over-quarter basis is a critical metric to observe, as it may reflect changes in market dynamics or operational challenges.

Profitability

The profitability of Indegene Ltd in Q4FY25 is reflected in several key financial metrics. The company achieved a profit before tax of ₹133.50 crores, which is a decrease of 8.7% from ₹146.30 crores reported in Q3FY25. The tax expense for Q4FY25 was ₹38.70 crores, which increased by 5.7% from the previous quarter's tax expense of ₹36.60 crores. Consequently, the profit after tax for Q4FY25 stood at ₹94.80 crores, showing a decline of 13.6% from the ₹109.70 crores reported in the previous quarter. Earnings per share for Q4FY25 were ₹4.20, down from ₹4.50 in Q3FY25, marking a 6.7% decrease.

Operating Metrics

Operating metrics for Indegene Ltd in Q4FY25 highlight certain trends in expenses and profitability. Total expenses in the fourth quarter amounted to ₹565.10 crores, decreasing by 7.6% from ₹611.80 crores in Q3FY25. This reduction in expenses is notable despite the decline in total income during the same period. The relationship between total income and total expenses is crucial for understanding the company's operational efficiency and cost management strategies. While total income has decreased, the company managed to reduce expenses, which aligns with the observed pattern of profitability metrics such as profit before and after tax. However, specific financial ratios such as the P/E ratio, debt-to-equity ratio, and current ratio cannot be calculated from the data provided, as necessary components and values are missing.